Most Read Articles
04 Oct 2020
Obesity does not appear to be strongly correlated with an increased risk for febrile neutropaenia during levofloxacin prophylaxis in patients with haematological malignancies receiving intermediate-risk myelosuppressive chemotherapy, suggests a study.
Roshini Claire Anthony, 3 days ago

Initiation or switch to the single-tablet regimen of bictegravir/emtricitabine/tenofovir alafenamide (TAF) led to low HIV-1 RNA viral load in people living with HIV (PLHIV), according to the BICSTaR study presented at HIV Glasgow 2020.

09 Nov 2020
Use of corticosteroids appears to be an effective treatment for paediatric drug reaction with eosinophilia and systemic symptoms (DRESS), suggest the results of a recent study. In severe cases, corticosteroids used in conjunction with intravenous immunoglobulin result in fast clinical improvement.
07 Aug 2020
Concomitant treatment with a nonsteroidal anti-inflammatory drug (NSAID) following myocardial infarction (MI) is associated with a higher risk of cardiovascular and bleeding events, a study has shown.

Antibiotics, corticosteroids reduce treatment failure in adults with COPD exacerbation

28 Feb 2020

Use of antibiotics and systemic corticosteroids can help decrease treatment failure in adults with mild-to-severe exacerbation of chronic obstructive pulmonary disease (COPD), results of a systematic review and meta-analysis have shown.

The investigators performed English-language searches of several bibliographic sources from database inception through 2 January 2019 and were able to identify 68 randomized controlled trials. Included studies enrolled adults with COPD exacerbation treated in out- or inpatient settings other than intensive care and compared pharmacologic therapies with placebo, usual care or other interventions. In addition, two independent reviewers extracted data and rated study quality and strength of evidence (SOE).

Treatment with antibiotics for 3–14 days, compared with placebo or management without antibiotics, led to increased resolution of COPD exacerbation (odds ratio [OR], 2.03, 95 percent confidence interval [CI], 1.47–2.80; moderate SOE) and less treatment failure at the end of intervention (OR, 0.54, 95 percent CI, 0.34–0.86; moderate SOE), independent of severity of exacerbation in out- and inpatients.

In addition, systemic corticosteroids given for 9–56 days, compared with placebo, in out- and inpatients also resulted in less treatment failure at the end of intervention (OR, 0.01, 95 percent CI, 0.00–0.13; low SOE) but was associated with a higher number of total and endocrine-related adverse events (AEs).

On the other hand, there were insufficient evidence for other pharmacologic intervention (eg, aminophyllines, magnesium sulfate, anti-inflammatory agents, inhaled corticosteroids and short-acting bronchodilators), compared with placebo or usual care, in inpatients, showing either no or inconclusive effects (except for mucolytic erdosteine) or improvement only in lung function.

The study was limited by scant evidence for many interventions, and several trials had unclear or high risk of bias and inadequate reporting of AEs, according to the investigators.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacist - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
04 Oct 2020
Obesity does not appear to be strongly correlated with an increased risk for febrile neutropaenia during levofloxacin prophylaxis in patients with haematological malignancies receiving intermediate-risk myelosuppressive chemotherapy, suggests a study.
Roshini Claire Anthony, 3 days ago

Initiation or switch to the single-tablet regimen of bictegravir/emtricitabine/tenofovir alafenamide (TAF) led to low HIV-1 RNA viral load in people living with HIV (PLHIV), according to the BICSTaR study presented at HIV Glasgow 2020.

09 Nov 2020
Use of corticosteroids appears to be an effective treatment for paediatric drug reaction with eosinophilia and systemic symptoms (DRESS), suggest the results of a recent study. In severe cases, corticosteroids used in conjunction with intravenous immunoglobulin result in fast clinical improvement.
07 Aug 2020
Concomitant treatment with a nonsteroidal anti-inflammatory drug (NSAID) following myocardial infarction (MI) is associated with a higher risk of cardiovascular and bleeding events, a study has shown.